KEDRION BIOPHARMA INC. 401(K) PLAN
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
KEDRION BIOPHARMA INC.
This 401(k) plan holds $27M in total assets and serves 1,056 participants as of 2022. It is sponsored by KEDRION BIOPHARMA INC. in New Jersey. The plan reported a net loss of $2M for the year.
What the Filing Says About KEDRION BIOPHARMA INC. 401(K) PLAN
KEDRION BIOPHARMA INC. 401(K) PLAN is a 401(k) retirement plan sponsored by KEDRION BIOPHARMA INC., headquartered in New Jersey. As of the 2022 Form 5500 filing, the plan reports $27M in total end-of-year assets and covers 1,056 participants across the Healthcare & Social Assistance industry. The sponsor's EIN on file with the U.S. Department of Labor is 383841851, and the plan has been effective since 2000-01-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from $29M at the beginning of 2022 to $27M at year-end — a decline of 6.9%. Net assets (after liabilities) closed the year at $27M, with reported net income of $-1,983,135 driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | $29M |
| Total Assets (End of Year) | $27M |
| Net Assets (End of Year) | $27M |
| Net Income | $-1,983,135 |
| Plan Type | 401(k) |
| Employer EIN | 383841851 |
| Plan Effective Date | 2000-01-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (KEDRION BIOPHARMA INC.)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 1,056 | $27M |
| 2023 | 1 | 1,245 | $33M |
| 2024 | 1 | 2,421 | $61M |
Nearby 401(k) Plans in New Jersey
Peer 401(k) plans — same state, same plan type — ranked by total assets.
- JPMORGAN CHASE 401(K) SAVINGS PLAN $44.6B · 176,610
- VERIZON SAVINGS PLAN FOR MANAGEMENT EMPLOYEES $27.8B · 78,072
- JOHNSON AND JOHNSON SAVINGS PLAN $22.2B · 41,291
- MERCK US SAVINGS PLAN $13.4B · 26,850
- THE PRUDENTIAL EMPLOYEE SAVINGS PLAN $10.4B · 16,321
Related Data
Guides
Frequently Asked Questions
How much money is in the KEDRION BIOPHARMA INC. 401(K) PLAN? ▼
What type of plan is KEDRION BIOPHARMA INC. 401(K) PLAN? ▼
Who sponsors the KEDRION BIOPHARMA INC. 401(K) PLAN? ▼
How did KEDRION BIOPHARMA INC. 401(K) PLAN perform in 2022? ▼
Where can I find official filings for KEDRION BIOPHARMA INC. 401(K) PLAN? ▼
How does KEDRION BIOPHARMA INC. 401(K) PLAN compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2022.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 383841851.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.